Research indicates that thousands more patients may benefit from currently available cancer treatments.

Published Date: 02 Aug 2023

More people may benefit from taking PARP inhibitor medications like olaparib, which are already used to treat some inherited cases of breast, ovarian, and prostate cancer, according to new research that was recently published in Nature Genetics.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An ancient signaling pathway and 20 years of research offer hope for rare cancer

2.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

3.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

4.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

5.

Prostate cancer detection with PET CT and PET MRI is comparable.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot